Cardiology

In the largest analysis of its kind, a team of investigators from Italy are shedding new light on the impact of aspirin use and risk of cancers of the digestive tract.

Overweight, hypertensive patients who enrolled in a self-administered, internet-based health management program had better outcomes than patients who did not join the program, according to recent study findings.

Aspirin, the popular and well-established therapy for cardiovascular disease may have a new role in treating cancers of the digestive tract.

In an effort to settle the debate surrounding the use of ACE inhibitors (ACEI) and ARBs during the ongoing coronavirus disease 2019 (COVID-19) outbreak, investigators from Perelman School of Medicine at the University of Pennsylvania, recently launched a new clinical trial.  The REPLACE COVID trial plans to recruit 152 hospitalized patients already taking medications from the classes, with the goal of determining whether discontinuing use affects the severity of disease symptoms.

New research is shedding light on the long-term outcomes of percutaneous coronary intervention in patients with stable ischemic heart disease.

Bhatt leads discussion on a new AHA statement regarding one of the most advancing fields of cardiovascular care.

New research from the California Department of Public Health is shedding new light on the impact of wildfire smoke on out-of-hospital cardiac arrest.

Using combined data from the National Ocean Atmospheric Association’s (NOAA) Hazard Mapping System and the Cardiac Arrest Registry to Enhance Survival (CARES) from 14 California counties, investigators from the California’s Department of Public Health have uncovered a startling link between wildfires and a sharp rise in out-of-hospital cardiac arrests.  Heavy wildfire smoke increased risk of out-of-hospital cardiac arrests by as much as 70%, researchers report.

Mitchell Elkind, M.D. , neurologist and epidemiologist at Columbia University discusses the neurological changes seen in COVID-19 patients, including an increased risk of stroke and seizure.

Dr. Mariell Jessup, Chief Science and Medical Officer at the AHA discusses the cardiac dangers of combining hydroxychloroquine and azithromycin to treat coronavirus patients with underlying heart disease, the controversy surrounding putting medical students and trainees on the frontlines of COVID-19 too soon, and the changing roles of telemedicine.

A new Emory University-led study is shedding more light on the impact mental stress can have on cardiovascular health.

Sr. Editor of Practical Cardiology Gretchen Cuda Kroen interviews Dr. Nir Uriel, a cardiologist on the frontlines of the COVID-19 epidemic in NYC.  Dr. Uriel describes the cardiovascular presentations of COVID-19 he and his colleagues are seeing, how they diverge from the conventional respiratory presentation, and what this means for the diagnosis and treatment strategies for these patients.

The intervention is no better than usual care at improving the mood or burden of those caring for adults with advanced heart failure, according to new findings.

A discussion about a recent scientific statement outlining the treatment of coronary artery disease in type 2 diabetics from the AHA with statement co-author Deepak Bhatt, MD.

New research from Emory University is shedding light on a potential link between post-traumatic stress disorder (PTSD) and mental stress-induced myocardial ischemia in patients with stable coronary artery disease.  The study, led by Viola Vaccarino, MD, PhD, of the department of epidemiology at Emory University Rollins School of Public Health, found that patients with stable coronary artery disease who survived a recent myocardial infarction (MI) and had PTSD were at a greater risk of developing myocardial ischemia than those who did not have PTSD.

Investigators from Saint Louis University discuss a new comparison of 2 drug classes that could reduce the risk of adverse cardiovascular events.

A new study analyzing at-home blood pressure devices available for purchase online has found most are not validated—bringing their accuracy into question.

A new scientific statement from the AHA offers guidance to clinicians tasked with treating CAD in patients with type 2 diabetes.

A discussion with Paul W. Armstrong of the University of Alberta, on the pandemic's effect on common ICU conditions.

New research is shining light on the use of eGFR as a biomarker for increased cardiovascular risk.

In a new study, investigators discover the hazard of depression increases with each BMI category.

Paul W. Armstrong, MD, joins to discuss the virtual cardiology sessions, as well as his team's new findings for vericiguat in high-risk heart failure.

Results of a 26-year study examine the impact of a dozen different lifestyle interventions in a cohort from the Nurses Health Study.

A new retrospective analysis suggests CABG may be more appropriate for CAD patients with severely reduced left ventricular ejection fraction.

Gretchen Cuda Kroen, Senior Editor of Practical Cardiology interviews Stephen Kopecky, MD a cardiologist and specialist in Preventative Medicine from the Mayo Clinic about what patients and their physicians need to know about staying healthy with heart disease in the wake of COVID19.